Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Sales | 6,561 | 3,529 | 4,056 | 4,230 | 4,657 |
Cost of Goods | 10,491 | 9,405 | 11,142 | 9,164 | 9,646 |
Gross Profit | -3,930 | -5,877 | -7,086 | -4,934 | -4,989 |
Operating Expenses | 7,900 | 7,737 | 9,604 | 9,022 | 9,074 |
Operating Income | -11,339 | -13,208 | -16,548 | -13,791 | -13,417 |
Interest Expense | 2,073 | 1,541 | 1,438 | 1,403 | 1,359 |
Other Income | 199 | 1,681 | -52 | 58 | 29 |
Pre-tax Income | -13,212 | -13,068 | -18,038 | -15,136 | -14,748 |
Net Income Continuous | -13,212 | -13,068 | -18,038 | -15,136 | -14,748 |
Net Income | $-13,212 | $-13,068 | $-18,038 | $-15,136 | $-14,748 |
EPS Basic Total Ops | -0.25 | -0.28 | -0.38 | -0.33 | -0.35 |
EPS Basic Continuous Ops | -0.25 | -0.28 | -0.39 | -0.33 | -0.35 |
EPS Diluted Total Ops | -0.25 | -0.28 | -0.38 | -0.33 | -0.35 |
EPS Diluted Continuous Ops | -0.25 | -0.28 | -0.39 | -0.33 | -0.35 |
EBITDA(a) | $-10,473 | $-12,194 | $-15,364 | $-12,697 | $-12,338 |